Literature DB >> 13341909

Anticholinesterase activity of ethyleneimines and certain other cytotoxic agents.

K BULLOCK.   

Abstract

Entities:  

Keywords:  CHOLINESTERASE/antagonists

Mesh:

Substances:

Year:  1956        PMID: 13341909      PMCID: PMC1216200          DOI: 10.1042/bj0630484

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


× No keyword cloud information.
  8 in total

1.  Attempts at chemotherapy of malignant diseases.

Authors:  F BERGEL
Journal:  J Pharm Pharmacol       Date:  1955-05       Impact factor: 3.765

2.  The enzymic hydrolysis of alkyl fluoroacetates and related compounds.

Authors:  F BERGMANN; A SHIMONI
Journal:  Biochem J       Date:  1953-08       Impact factor: 3.857

3.  A cholinesterase inhibitor derived from OO-diethyl O-p-nitrophenyl thiophosphate in vivo.

Authors:  J C GAGE
Journal:  Biochem J       Date:  1953-06       Impact factor: 3.857

4.  The action, in vitro and in vivo, of some nitrogen mustards on haemolytic complement.

Authors:  W M WATKINS; A WORMALL
Journal:  Biochem J       Date:  1952-11       Impact factor: 3.857

5.  The reactivity of radiomimetic compounds. I. Cross-linking of proteins.

Authors:  P ALEXANDER; M FOX; K A STACEY; L F SMITH
Journal:  Biochem J       Date:  1952-10       Impact factor: 3.857

6.  The inhibition of erythrocyte cholinesterase by tri-esters of phosphoric acid. I. Diethyl p nitrophenyl phosphate (E600) and analogues.

Authors:  W N ALDRIDGE; A N DAVISON
Journal:  Biochem J       Date:  1952-04       Impact factor: 3.857

7.  Studies on cholinesterase. VII. The active surface of acetylcholine esterase derived from effects of pH on inhibitors.

Authors:  I B WILSON; F BERGMANN
Journal:  J Biol Chem       Date:  1950-08       Impact factor: 5.157

8.  Return of cholinesterase activity in the rat after inhibition by organophosphorus compounds. I. Diethyl p-nitro-phenyl phosphate (E 600, paraoxon).

Authors:  A N DAVISON
Journal:  Biochem J       Date:  1953-07       Impact factor: 3.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.